Dow Up 0.47% Nasdaq Up 1.28%

ACADIA Pharmaceuticals Inc. (ACAD)

-NasdaqGS
26.87 Up 0.29(1.09%) 10:16AM EDT - Nasdaq Real Time Price
Prev Close:26.58
Open:26.88
Bid:26.69 x 100
Ask:26.76 x 300
1y Target Est:34.92
Beta:2.36
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:26.41 - 26.96
52wk Range:15.64 - 32.00
Volume:192,144
Avg Vol (3m):1,187,570
Market Cap:2.67B
P/E (ttm):N/A
EPS (ttm):-0.67
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ACADUp 1.09%2.67B
AZNUp 0.40%86.17B
LLYUp 1.51%68.64B
PFEUp 1.06%178.97B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):7,889.58
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.85
Quarterly EPS Est (Sep-14) :-0.22
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-1.53

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback